322 related articles for article (PubMed ID: 31687101)
1. Cardiovascular Risk of Proton Pump Inhibitors.
Ariel H; Cooke JP
Methodist Debakey Cardiovasc J; 2019; 15(3):214-219. PubMed ID: 31687101
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.
Sun S; Cui Z; Zhou M; Li R; Li H; Zhang S; Ba Y; Cheng G
Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27577963
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
5. What are the risks of long-term PPI use for GERD symptoms in patients > 65 years?
Devitt J; Lyon C; Swanson SB; DeSanto K
J Fam Pract; 2019 Apr; 68(3):E18-E19. PubMed ID: 31039222
[No Abstract] [Full Text] [Related]
6. Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.
Holtmann G; Bigard MA; Malfertheiner P; Pounder R
Int J Clin Pharm; 2011 Jun; 33(3):493-500. PubMed ID: 21472476
[TBL] [Abstract][Full Text] [Related]
7. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?
Corsonello A; Lattanzio F
Trends Cardiovasc Med; 2019 Aug; 29(6):353-360. PubMed ID: 30389278
[TBL] [Abstract][Full Text] [Related]
9. Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.
Lin BM; Curhan SG; Wang M; Jacobson BC; Eavey R; Stankovic KM; Curhan GC
Ear Hear; 2017; 38(1):21-27. PubMed ID: 27556519
[TBL] [Abstract][Full Text] [Related]
10. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
[TBL] [Abstract][Full Text] [Related]
11. Treatment of gastroesophageal reflux disease.
Pettit M
Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease.
Kierkus J; Oracz G; Korczowski B; Szymanska E; Wiernicka A; Woynarowski M
Drug Saf; 2014 May; 37(5):309-16. PubMed ID: 24706290
[TBL] [Abstract][Full Text] [Related]
15. Potential adverse effects of proton pump inhibitors.
Coté GA; Howden CW
Curr Gastroenterol Rep; 2008 Jun; 10(3):208-14. PubMed ID: 18625128
[TBL] [Abstract][Full Text] [Related]
16. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease.
Sheikh I; Waghray A; Waghray N; Dong C; Wolfe MM
Am J Gastroenterol; 2014 Jun; 109(6):789-94. PubMed ID: 24896751
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors in the management of gastroesophageal reflux disease.
Hrelja N; Zerem E
Med Arh; 2011; 65(1):52-5. PubMed ID: 21534455
[TBL] [Abstract][Full Text] [Related]
18. Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB; Howden CW
Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of PPIs in children: we have questions.
Hassall E; Owen D
Dig Dis Sci; 2008 Apr; 53(4):1158-60, author reply 1161-2. PubMed ID: 18259863
[No Abstract] [Full Text] [Related]
20. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
Cohen S; Bueno de Mesquita M; Mimouni FB
Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
